Podcast
Drug Pricing and Market Access: Key Takeaways From 2025 and Outlook for 2026
February 3, 2026
Sabrina Aery, founder of Aery Policy and Access Partners, joins the Latham team to unpack what’s next for IRA implementation, 340B, and international reference pricing.
The drug pricing and market access policy space saw a lot of change in 2025, and the pace is not slowing down. In this episode of Connected With Latham, pharmaceutical industry veteran Sabrina Aery, founder of Aery Policy and Access Partners, joins Washington, D.C. partner Chris Schott and associate Danny Machado for a wide-ranging discussion of key 2025 takeaways and what to expect in 2026.
Listen here or subscribe via Apple Podcasts, Spotify, or anywhere else you listen to podcasts.